DAWN
NASDAQ · Biotechnology
Day One Biopharmaceuticals I
$21.53
+0.04 (+0.19%)
DAWN News30 articles
Altria Slips for Fifth Day as Nicotine Pouch Competition Intensifies
Altria shares fell 1.3% to $68.12, extending a five-session losing streak despite a Q1 earnings beat. Rising competition in the nicotine pouch market and declining cigarette volumes weigh on the stock ahead of its May 14 annual meeting.
Nifty and Sensex Post Weekly Gains Despite Friday Selloff, Oil Above $100 Sparks Caution
Indian stocks fell Friday, but Nifty and Sensex posted weekly gains. Brent crude above $100 on U.S.-Iran tensions pressures the rupee and stokes inflation fears.
ASX 200 Weekly Gain Erased by Friday Slump Amid Oil Shock and RBA Rate Hike
Australian stocks ended the week barely higher after a Friday sell-off erased A$50 billion. The RBA's rate hike and oil price volatility weighed heavily on financials.
Pool Corp Shares Drop 7% on CEO Change and Investor Day Delay
Pool Corporation shares dropped over 7% Tuesday following the abrupt CEO change and Investor Day postponement, despite reaffirming 2026 earnings outlook.
Gloo Acquires EnterpriseMarketdesk to Boost Workday AI Services
Gloo closed its acquisition of EnterpriseMarketdesk, adding Workday consulting and support for nonprofits and mid-market clients. Shares fell 1.1% to $6.97.
Filtronic Faces Key Test as Space and Defence Orders Await Tuesday Trading
Filtronic shares are under scrutiny as London markets reopen Tuesday, with investors eyeing the potential for recent space and defence contract wins to translate into larger, recurring revenue streams.
Fitch Upgrades Citigroup Outlook as Fraser Prepares for Key Investor Day
Fitch Ratings revised Citigroup's outlook to positive, citing progress in CEO Jane Fraser's restructuring. Q1 net income hit $5.8B on $24.6B revenue, with shares closing at $127.44.
Workday's Q1 Earnings: AI Strategy Faces Pivotal Test on May 21
Workday reports fiscal Q1 earnings on May 21, with subscription revenue guidance of $2.335B. The company's AI push faces a key test amid competition and investor concerns.
monday.com Shares Surge Ahead of Earnings and Legal Deadline
monday.com shares surged 10% to $72.74 ahead of its Q1 earnings report and a key lawsuit deadline. The company faces allegations of misleading investors on growth outlook.
Tempus AI Faces Pivotal May with Q1 Results and Inaugural Investor Day
Tempus AI reports Q1 results May 5 and holds its first investor day May 29, with Merck CEO highlighting the partnership. Stock trades near $55.44 with a $9.7B market cap.
Gold Slides for Third Day as Fed Policy and Iran Tensions Weigh
Gold dropped for a third day to $4,545.20 as traders weighed Fed rate policy and Iran war fears. Brent crude neared $119, Treasury yields climbed.
Citi's $52 Million Hire Faces New Questions Ahead of Investor Day
Citigroup's high-profile $52 million hire of Vis Raghavan is under new scrutiny after reports he was ousted from JPMorgan amid years of complaints, just ahead of Citi's May 7 investor day.
ASX 200 Falls for Sixth Day as Oil Rally Stokes RBA Rate Jitters
The ASX 200 fell for a sixth consecutive session, closing at 8,710.7, as surging oil prices heightened inflation fears ahead of key CPI data.
Lilly's Oral Obesity Drug Foundayo Trails Novo Nordisk's Wegovy in Early Prescription Data
Eli Lilly's Foundayo prescriptions hit 3,707 in week two, well behind Novo Nordisk's Wegovy. Lilly shares dropped 4%, while Novo gained 6%. Analysts advise caution on early figures.
Novo Nordisk Wegovy Pill Prescriptions Surge Past Eli Lilly's Foundayo in Early Launch Race
Novo Nordisk's Wegovy pill recorded 18,410 U.S. prescriptions in its second week, far outpacing Eli Lilly's Foundayo at 3,707, according to IQVIA data. Novo shares rose, Lilly fell.
Hims Expands Branded GLP-1 Access with Lilly's Zepbound and Foundayo
Hims & Hers Health now offers Eli Lilly's Zepbound and Foundayo via LillyDirect, broadening its branded GLP-1 lineup amid a competitive cash-pay market.
ASX 200 Posts Weekly Gain Despite Friday Dip, Middle East Tensions Linger
Australian shares closed lower on Friday, trimming a robust weekly advance of 4.4%—the benchmark's best week since late 2022. Market sentiment remains cautious amid Middle East supply risks.
U.S. Markets Shut for Good Friday as March Jobs Data Looms
U.S. equity markets will be closed on Friday, April 3, 2026, for the Good Friday holiday, with trading resuming Monday, April 6. The key March employment report is scheduled for release during the market closure.
India's Banking System Braces for Year-End Holiday Disruptions
A series of bank holidays in India, coinciding with the financial year-end, is set to impact branch-based transactions like salary processing and cheque clearing from March 28 to April 3. Digital services will continue uninterrupted.
S&P 500 Tests Critical 200-Day Support Amid Oil Spike and Fed Uncertainty
The S&P 500 closed just above its 200-day moving average at 6,624.70, with technical analysts warning a break below 6,600 could trigger a sharp selloff. The market faces pressure from surging oil prices and reduced expectations for Federal Reserve rate cuts.
Soybeans Recover Midday; Infinity, PDD Show Deep Undervaluation
Soybean futures recovered from early losses Friday. Separate analyses suggest Infinity Natural Resources and PDD Holdings are significantly undervalued. Baytex Energy reported a major 2025 loss.
Barclays Boosts Chip Equipment Forecast, Lifts KLA Shares Ahead of Investor Day
KLA shares advanced Tuesday after Barclays significantly increased its chip equipment spending outlook, driven by AI data center needs. The firm now sees 2026 wafer fab equipment spending rising 24% to $139 billion.
Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal
French pharmaceutical firm Servier will acquire Day One Biopharmaceuticals for $2.5 billion, gaining the pediatric glioma treatment Ojemda. The deal offers a 68% premium to Day One's recent closing price.
Oil Prices Hover Near $81 as Hormuz Blockade Enters Fifth Day
Oil prices pared early gains Wednesday, with Brent crude trading near $81 a barrel as a prolonged blockade of the Strait of Hormuz continues to disrupt global supplies. Iraq has cut output by 1.5 million barrels per day.
Workday Shares Rebound on CEO Equity Grant After February Slump
Workday shares climbed approximately 7% in early trading Wednesday, recovering some losses after a recent decline. The move followed regulatory disclosures of new performance stock unit awards for top executives, including CEO Aneel Bhusri.
Wesfarmers Shares Drop 5% in Two Days Amid ASX Selloff
Wesfarmers shares declined for a second consecutive session, dropping roughly 5% over two days as broader Asian markets sold off on geopolitical concerns and oil price volatility.
Accelerant Stock Retreats in Premarket Following Friday's Surge
Accelerant Holdings stock declined nearly 3% in premarket trading Monday, paring back a significant 10% surge from the previous session. Investors are focused on the company's upcoming audited financial results and 2026 guidance scheduled for March 19.
Accelerant Stock Retreats in Premarket Following Friday's Surge
Accelerant Holdings stock declined nearly 3% in premarket activity, paring a sharp rally from the prior session. The market now focuses on the company's upcoming audited financial release and forward outlook.
Accelerant Stock Retreats in Premarket Following Friday's Surge
Accelerant Holdings stock declined nearly 3% in premarket trading, giving back a portion of its sharp 10% rally from Friday. The market now focuses on the company's upcoming audited financial release and forward outlook.
IREN Plunges 7% on Friday Despite MSCI USA Index Inclusion
Shares of IREN Limited dropped 7.4% on Friday, closing at $40.95, even as the company was added to the MSCI USA Index. Trading volume surged to 52.66 million shares amid a broad market sell-off.